These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29896411)

  • 41. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies.
    Power JH; Shannon JM; Blumbergs PC; Gai WP
    Am J Pathol; 2002 Sep; 161(3):885-94. PubMed ID: 12213717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipids as
    Ikenaka K; Suzuki M; Mochizuki H; Nagai Y
    Front Neurosci; 2019; 13():693. PubMed ID: 31333408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains.
    Imamura K; Hishikawa N; Ono K; Suzuki H; Sawada M; Nagatsu T; Yoshida M; Hashizume Y
    Acta Neuropathol; 2005 Feb; 109(2):141-50. PubMed ID: 15619128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
    Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
    Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
    Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
    Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffuse Lewy body disease.
    Lin YW; Truong D
    J Neurol Sci; 2019 Apr; 399():144-150. PubMed ID: 30807982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
    Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Riboldi GM; Di Fonzo AB
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. R869C mutation in molecular motor
    Goldstein O; Gana-Weisz M; Shiner T; Attar R; Mordechai Y; Waldman YY; Bar-Shira A; Thaler A; Gurevich T; Mirelman A; Giladi N; Orr-Urtreger A
    Alzheimers Dement (Amst); 2021; 13(1):e12143. PubMed ID: 34124335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease.
    Downes JJ; Priestley NM; Doran M; Ferran J; Ghadiali E; Cooper P
    Behav Neurol; 1999 Jan; 11(3):173-83. PubMed ID: 22387597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease.
    Downes JJ; Priestley NM; Doran M; Ferran J; Ghadiali E; Cooper P
    Behav Neurol; 1998; 11(3):173-183. PubMed ID: 11568418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Autonomic Dysfunction and Skin Biopsy in Dementia with Lewy Bodies].
    Orimo S
    Brain Nerve; 2018 Aug; 70(8):915-927. PubMed ID: 30082501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to diagnose dementia with Lewy bodies: state of the art.
    Geser F; Wenning GK; Poewe W; McKeith I
    Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.